Back to All Applications
Scientific Research

Particle Accelerator Magnets

REBCO superconducting dipole and quadrupole focusing magnets for synchrotrons, proton therapy centers, and high-energy colliders.

10-16T
Dipole Field Strength
12-77K
Operating Range
75%
Weight Reduction
<1μm
Beam Precision

Pushing the Boundaries of High Energy Physics

The next generation of high-energy particle accelerators requires bending and focusing fields that far exceed the limits of legacy NbTi and even advanced Nb3Sn superconducting magnets. By transitioning to REBCO (Rare-Earth Barium Copper Oxide) technology, we are redefining what is physically possible in fundamental physics research and medical applications.

At CERN's Large Hadron Collider (LHC), the upcoming HL-LHC upgrade is deploying Nb3Sn for 11T bending magnets. However, future collider designs such as the Future Circular Collider (FCC) demand continuous fields of 16 Tesla or more. REBCO can achieve these ultra-high fields at the same, or even more favorable, cryogenic cost footprint compared to LTS alternatives.

  • Ultra-High Fields (16+ Tesla)

    Enables more compact accelerators or exponentially higher collision energies in existing tunnels.

  • Higher Operating Temperatures

    Operation at 10K-20K significantly reduces the massive cryogenic infrastructure required by 1.9K superfluid helium systems.

Medical Application: Proton Therapy

Beyond basic science, REBCO magnets are revolutionizing clinical cancer treatments. Proton therapy centers rely on massive cyclotrons to accelerate particles for precision tumor targeting.

Gantry Weight Reduction

Conventional
100 Tons
HTS REBCO
25 Tons

Using 3T REBCO cyclotron magnets enables room-temperature, compact gantry systems. This reduction in weight and footprint brings the cost of proton therapy centers down dramatically, making the treatment accessible to smaller regional hospitals.

Ecosystem

Key Industry Implementers

Organizations pushing the boundaries of particle accelerator technology with HTS.

CERN FCC Study

Exploring 16T to 20T dipole magnets for the Future Circular Collider, utilizing advanced high-temperature superconductors.

ProNova Solutions

Developing compact, superconducting proton therapy systems that lower the barrier to entry for advanced cancer treatment.

Mevion Medical

Pioneers in compact single-room proton therapy installations powered by powerful superconducting synchrocyclotrons.